Abrams Bison Investments LLC Has $81.23 Million Stock Position in Acadia Healthcare Company, Inc. $ACHC

Abrams Bison Investments LLC grew its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 96.7% during the 2nd quarter, Holdings Channel.com reports. The firm owned 3,580,000 shares of the company’s stock after purchasing an additional 1,760,000 shares during the period. Acadia Healthcare accounts for about 7.6% of Abrams Bison Investments LLC’s portfolio, making the stock its 6th largest holding. Abrams Bison Investments LLC’s holdings in Acadia Healthcare were worth $81,230,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Allworth Financial LP boosted its stake in Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after purchasing an additional 1,177 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its position in shares of Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock valued at $38,000 after acquiring an additional 1,234 shares during the period. CWM LLC grew its stake in shares of Acadia Healthcare by 105.1% in the second quarter. CWM LLC now owns 2,633 shares of the company’s stock valued at $60,000 after acquiring an additional 1,349 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC increased its position in Acadia Healthcare by 639.5% during the second quarter. Steward Partners Investment Advisory LLC now owns 3,372 shares of the company’s stock worth $77,000 after acquiring an additional 2,916 shares during the period.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Bank of America downgraded shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $21.50 to $13.00 in a report on Wednesday, December 3rd. Barclays cut their price target on Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating for the company in a research note on Thursday, December 4th. Cantor Fitzgerald set a $17.00 price objective on Acadia Healthcare in a research note on Wednesday, December 3rd. Leerink Partners reiterated a “market perform” rating and set a $14.00 target price (down from $25.00) on shares of Acadia Healthcare in a research report on Wednesday, December 3rd. Finally, Leerink Partnrs lowered Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 3rd. Eight equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $23.17.

Acadia Healthcare Trading Down 1.2%

Shares of ACHC stock opened at $14.28 on Friday. Acadia Healthcare Company, Inc. has a fifty-two week low of $12.63 and a fifty-two week high of $47.08. The stock’s fifty day moving average price is $19.53 and its two-hundred day moving average price is $21.40. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44. The company has a market cap of $1.32 billion, a PE ratio of 12.21, a P/E/G ratio of 3.41 and a beta of 0.91.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.01. The business had revenue of $851.57 million during the quarter, compared to the consensus estimate of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.Acadia Healthcare’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Equities analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.